Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2017 Mar 28;317(12):1252-1257.
doi: 10.1001/jama.2017.1462.

Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force; Kirsten Bibbins-Domingo  1 , David C Grossman  2 , Susan J Curry  3 , Michael J Barry  4 , Karina W Davidson  5 , Chyke A Doubeni  6 , Mark Ebell  7 , John W Epling Jr  8 , Jessica Herzstein  9 , Alex R Kemper  10 , Alex H Krist  11 , Ann E Kurth  12 , C Seth Landefeld  13 , Carol M Mangione  14 , Maureen G Phipps  15 , Michael Silverstein  16 , Melissa A Simon  17 , Chien-Wen Tseng  18
Affiliations
Practice Guideline

Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force et al. JAMA. .

Abstract

Importance: Celiac disease is caused by an immune response in persons who are genetically susceptible to dietary gluten, a protein complex found in wheat, rye, and barley. Ingestion of gluten by persons with celiac disease causes immune-mediated inflammatory damage to the small intestine.

Objective: To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for celiac disease.

Evidence review: The USPSTF reviewed the evidence on the accuracy of screening in asymptomatic adults, adolescents, and children; the potential benefits and harms of screening vs not screening and targeted vs universal screening; and the benefits and harms of treatment of screen-detected celiac disease. The USPSTF also reviewed contextual information on the prevalence of celiac disease among patients without obvious symptoms and the natural history of subclinical celiac disease.

Findings: The USPSTF found inadequate evidence on the accuracy of screening for celiac disease, the potential benefits and harms of screening vs not screening or targeted vs universal screening, and the potential benefits and harms of treatment of screen-detected celiac disease.

Conclusions and recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons. (I statement).

PubMed Disclaimer

Comment in

Summary for patients in

  • Screening for Celiac Disease.
    Jin J. Jin J. JAMA. 2017 Mar 28;317(12):1286. doi: 10.1001/jama.2017.1749. JAMA. 2017. PMID: 28350930 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types